Avanos Medical (AVNS) Return on Capital Employed (2014 - 2026)

Avanos Medical has disclosed Return on Capital Employed across 13 years of filings, most recently posting 6.77% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 6.77%, up 3246.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.77% (up 3246.0% YoY), and the FY2025 annual result was 6.49%, up 2502.0% from the prior year.
• Return on Capital Employed came in at 6.77% for Q1 2026 at Avanos Medical, roughly flat from 6.8% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 3.03% in Q4 2022 to a low of 53.3% in Q3 2025.
• The 5-year median for Return on Capital Employed is 0.28% (2023), against an average of 10.39%.
• Across the five-year window, Return on Capital Employed tumbled 5562 bps in 2025 and surged 3246 bps in 2026, its largest moves.
• Avanos Medical's Return on Capital Employed stood at 3.03% in 2022, then plunged by 91 bps to 0.28% in 2023, then plunged by 11320 bps to 31.97% in 2024, then jumped by 79 bps to 6.8% in 2025, then increased by 0 bps to 6.77% in 2026.
• The last three Return on Capital Employed figures came in at 6.77% (Q1 2026), 6.8% (Q4 2025), and 53.3% (Q3 2025), per Business Quant data.